{
    "2021-11-29": [
        [
            {
                "time": "2022-11-28",
                "original_text": "医药行业周报：OMICRON成热议 CDMO和上游边际改善",
                "features": {
                    "keywords": [
                        "OMICRON",
                        "CDMO",
                        "上游",
                        "边际改善"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-29",
                "original_text": "南财脱水研报丨奥密克戎对医疗板块影响如何，复盘德尔塔或能参考",
                "features": {
                    "keywords": [
                        "奥密克戎",
                        "医疗板块",
                        "德尔塔",
                        "复盘"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-11-30",
                "original_text": "海外机构调研股名单 智飞生物最受关注",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "海外机构",
                        "调研"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-01",
                "original_text": "盛通股份：公司已与国内获批上市的中国生物、智飞生物等新冠疫苗生产企业合作，订单量充盈",
                "features": {
                    "keywords": [
                        "盛通股份",
                        "中国生物",
                        "智飞生物",
                        "新冠疫苗",
                        "订单量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-02",
                "original_text": "变异毒株来势汹汹！高回撤绩优热门股名单来了",
                "features": {
                    "keywords": [
                        "变异毒株",
                        "高回撤",
                        "绩优",
                        "热门股"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-12-03",
                "original_text": "医药生物行业2022年投资策略报告：返璞归真 迎接高质量发展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "高质量发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-04",
                "original_text": "生物医药行业周报：加强新时代老龄工作的意见发布 康复行业或将受益",
                "features": {
                    "keywords": [
                        "生物医药",
                        "老龄工作",
                        "康复行业",
                        "意见发布"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-05",
                "original_text": "智飞生物：公司现有预防新冠产品智克威得临床试验数据显示有很好的安全性和防病效果",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠",
                        "智克威得",
                        "安全性",
                        "防病效果"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-06",
                "original_text": "智飞生物：正积极推进重组新冠疫苗的后续认证工作",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠疫苗",
                        "认证工作"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-07",
                "original_text": "智飞生物：mRNA技术在疫苗开发、肿瘤治疗等方面有优势",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "mRNA技术",
                        "疫苗开发",
                        "肿瘤治疗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-08",
                "original_text": "医药板块反弹强烈，硕世生物涨超15%",
                "features": {
                    "keywords": [
                        "医药板块",
                        "反弹",
                        "硕世生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-09",
                "original_text": "超级病毒全球刷屏，投资逻辑彻底变了？一类股危险了",
                "features": {
                    "keywords": [
                        "超级病毒",
                        "投资逻辑",
                        "一类股"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}